Acarix publishes the annual report for 2021

3 years ago

Press release Malmö, Sweden, April 20, 2022   Acarix publishes the annual report for 2021 Today, Wednesday April 20, Acarix is publishing…

Jounce Therapeutics to Participate in Raymond James LILRB/ILT Symposium: Deep Dive into “Myeloid Checkpoint” Therapeutics in Cancer

3 years ago

CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery…

PDS Biotech Chief Medical Officer, Lauren V. Wood, to Chair Session at the World Vaccine Congress

3 years ago

FLORHAM PARK, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a…

ProSomnus® Sleep Technologies to Present Three Posters at 2022 American Academy of Dental Sleep Medicine Annual Meeting

3 years ago

Company to showcase efficacy of its precision Oral Appliance Therapy devices in treating Obstructive Sleep ApneaSAN FRANCISCO, April 20, 2022 (GLOBE…

Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys Therapeutics

3 years ago

Elusys becomes wholly-owned biodefense subsidiary of NightHawk Plans to expand ANTHIM® distribution abroad DURHAM, N.C., April 20, 2022 (GLOBE NEWSWIRE)…

Lowell Farms Inc. Becomes Exclusive Distributor of Zippo Products for California Cannabis Dispensaries

3 years ago

Groundbreaking partnership includes debut of Lowell Farms-branded lighters within the Zippo portfolioSALINAS, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- In a…

OpGen’s Subsidiary Ares Genetics Commercially Launches New Sequencing and Analysis Services Globally

3 years ago

New services include pathogen identification, microbiome profiling and rapid turnaround sequencing of clinical isolatesROCKVILLE, Md., April 20, 2022 (GLOBE NEWSWIRE)…

Genenta to Host Expert Fireside Chat on Immuno Gene & Cell Therapy for Treatment of Solid Tumors

3 years ago

*** David Reardon, Luigi Naldini, Brad Loncar ***MILAN, Italy and NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) -- Genenta Science…

Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss

3 years ago

Clinical benefit again observed for OTO-413 versus placebo for multiple efficacy endpoints based on responder analysis at both Days 57…

Reduction of share capital

3 years ago

Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital